SCHEMBL29590760

SCHEMBL29590760

CC(O)CCCCC#Cc1ccc2c(c1)C(=O)N(C1CCC(=O)NC1=O)C2

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 18/20 0.56
▸ IKZF2 Q9UKS7 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27091090 1.00 CRBN (0.56) CRBNIKZF2
SCHEMBL29094767 0.87 CRBN (0.62) CRBN
SCHEMBL29440022 0.85 CRBN (0.58) CRBN
SCHEMBL22512119 0.85 CRBN (0.58) CRBN
SCHEMBL20913657 0.85 CRBN (0.62) CRBN
SCHEMBL21759455 0.83 CRBN (0.67) CRBN
SCHEMBL30128254 0.83 CRBN (0.67) CRBN
SCHEMBL26270745 0.83 CRBN (0.64) CRBNIKZF2
SCHEMBL24289050 0.83 CRBN (0.59) CRBNIKZF2
SCHEMBL23298772 0.81 CRBN (0.63) CRBNIKZF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225749-A1 COMPOUNDS AND METHODS OF TREATING CANCERS Cullgen (Shanghai), Inc. (CN) 2023-08-16 — — EP disclosed
CN-116583509-A Compounds and methods for treating cancer 上海睿跃生物科技有限公司 2023-08-11 — — CN disclosed
WO-2022073469-A1 COMPOUNDS AND METHODS OF TREATING CANCERS CULLGEN (SHANGHAI) , INC. (CN) 2022-04-14 — — WO disclosed
Send feedback